Skip to main content

Day: October 3, 2022

Global Eye Tracking Market Valuation to Reach $4.43 Billion by 2028 | Optical Eye Tracking to Generate 52% of Market Revenue

Global eye tracking market was valued at USD 635.51 million in 2021, and it is expected to reach a value of USD 4.43 billion by 2028, at a CAGR of 32.5% over the forecast period (2022–2028). Westford, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) — As our lives become increasingly digitized, it’s no surprise that the demand for eye tracking market is growing. This technology allows us to track and record eye movements, providing valuable insights into how we interact with digital devices and content. There are a variety of applications for eye tracking, from marketing research to usability testing to diagnosing conditions like ADHD. And as the technology continues to evolve, we can expect even more innovative uses for it in the future. There is a growing demand for eye tracking market in a variety of industries. This technology can...

Continue reading

urban-gro, Inc. Announces October 2022 Conference Participation

LAFAYETTE, Colo., Oct. 03, 2022 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), an integrated professional services and design-build firm offering solutions to the Controlled Environment Agriculture (“CEA”) and Commercial sectors, today announced its participation in the following October conferences.A.G.P.’s Fall Consumer Cannabis Conference, Virtual, October 4: Bradley Nattrass, Chairman & CEO, Dick Akright, CFO, and Dan Droller, EVP of Investor Relations & Corporate Development will participate in one-on-one investor meetings. Lucky Leaf Expo, Jackson, MS, October 7-8: urban-gro will be exhibiting at Booth 809. Sam Andras, EVP of Professional Services, will host a presentation on “Designing for Success: Key Considerations for a Cannabis Cultivation Facility” starting Saturday, October...

Continue reading

Global Blood Testing Market to Generate Revenue of $129.13 Billion by 2028 | Glucose Testing Holds Over 29% Market Share

Global blood testing market was valued at USD 73.9 billion in 2021, and is expected to reach a value of USD 129.13 billion by 2028, at a CAGR of 8.3% over the forecast period (2022–2028). Westford, USA, Oct. 03, 2022 (GLOBE NEWSWIRE) — Blood tests are important tools used to screen for and diagnose a variety of illnesses and conditions. They can be used to check for everything from anaemia and infections, to cancer and heart disease. With the help of blood tests, doctors can determine the best course of treatment for their patients. As the population continues to grow, so does the demand for blood testing market. In fact, the demand for blood tests is expected to increase by nearly 50% over the next decade. This is due in part to the aging population, as well as the increasing number of chronic illnesses that can be diagnosed with...

Continue reading

Trinity Biotech Announces The Appointment of Aris Kekedjian As Chairman and CEO

DUBLIN, Ireland, Oct. 03, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the appointment of Mr. Aris Kekedjian as CEO with effect from October 3, 2022. He succeeds Mr. Ronan O’Caoimh, co-founder of Trinity Biotech, who will remain on the Trinity Biotech plc Board of Directors to advise the Company going forward. In addition, Mr. Kekedjian has also assumed the role of Chairman of the Board of Directors of Trinity Biotech plc. Mr. Kekedjian’ s appointment as CEO of Trinity Biotech coincides with what Trinity Biotech believes is a period of fundamental transformation in the diagnostic landscape. The Company expects that increasing utilisation of digital health and virtual care, along with...

Continue reading

Titan NRG, Inc. (OTC: TTNN) Announces Contract with AmeriGas

Tucson, Arizona, Oct. 03, 2022 (GLOBE NEWSWIRE) — Publicly traded Titan NRG, Inc. (OTC: TTNN) (“Titan NRG”), operating as a downstream energy and transportation holding company through its wholly-owned subsidiaries, announces a contract between AmeriGas, the world’s largest propane company and NRG Rail, to throughput one million gallons through the Tucson rail terminal. In addition, NRG Dynamics will have the first right to provide transportation during the contract duration.  The time frame to complete the contract is expected to last around six weeks. “This is a very exciting opportunity to have the gallons flowing through our terminal while also getting the trucking revenue. We built the terminal to add another service that aligns with our business model and we’re beginning to see the fruits of that labor.”...

Continue reading

Altamira Therapeutics Continue Bentrio Clinical Trial for Seasonal Allergic Rhinitis in Australia

Bentrio USA Altamira Therapeutics Continue Bentrio Clinical Trial for Seasonal Allergic Rhinitis in AustraliaHAMILTON, BERMUDA , Oct. 03, 2022 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today announced that its “NASAR” clinical trial with its BentrioTM nasal spray for seasonal allergic rhinitis (SAR) has resumed the enrollment of study participants in Australia as its pollen season is starting up again. The NASAR trial, which will enroll a total of 100 patients suffering from SAR, is designed to compare the safety and efficacy of Bentrio against a saline nasal spray. Study participants are randomized at a 1:1 ratio to either receive Bentrio or control treatment via self-administration three times per day, or as needed,...

Continue reading

Sientra Supports Breast Cancer Awareness Month by Launching Educational Programs Designed to Empower Women

Sientra Partners with Breast Cancer Survivor, Miranda McKeon, to Encourage Women to Take Charge of Their Breast Reconstruction Journey SANTA BARBARA, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) — Sientra, Inc., a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced the launch of several initiatives in honor of Breast Cancer Awareness Month. as part of their long-standing commitment to breast cancer awareness and education Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Reshaping Lives: Full Circle. Miranda McKeon, a 20-year-old breast cancer survivor diagnosed with stage three breast cancer in June 2021, has partnered with Sientra to help raise awareness...

Continue reading

AITX’s Subsidiary Robotic Assistance Devices Group (RAD-G) Launches Efforts to Penetrate New Markets

Artificial Intelligence Technology Solutions, Inc. Image of an EV charging station and the AITX and RAD-G logos. AITX has announced that RAD-G will be supplying the EV charging infrastructure with RAD system-level components, adding safety and security features.Initiative Will Place RAD’s Industry-Proven AI-Based Security Hardware and Software in OEM Devices Detroit, Michigan, Oct. 03, 2022 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary, Robotic Assistance Devices, Group (RAD-G) has launched efforts to provide OEM system-level components to specific industries and clients outside of the Company’s existing security services industry footprint. To support and lead these efforts, the Company has named Ravi Gade as RAD-G’s OEM Program Director....

Continue reading

New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care

Patient One-Year Mortality Rate 5.6% with BVA-Guided Care Compared to 36.8% in Control Group – Data Presented at Key Scientific Meeting Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 blood test for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure from September 30th thru October 3rd, 2022, in Washington, DC. Jonathan Feldschuh, Chief Scientific Officer stated, “This study shows the substantial benefit of BVA-guided care for Medicare patients with heart failure. Reducing the mortality rate by 81% on a 30-day basis and...

Continue reading

Farmers & Merchants Bancorp, Inc. Announces Completion of the Peoples-Sidney Financial Corporation Acquisition

ARCHBOLD, Ohio, Oct. 03, 2022 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (“F&M”, “FMAO”, or the “Company”) (Nasdaq: FMAO), the holding company for Farmers & Merchants State Bank, announced today that it has completed the acquisition of Peoples-Sidney Financial Corporation (“Peoples” or “PPSF”). Lars Eller, President and CEO of F&M, stated, “We are thrilled to complete the Peoples acquisition, which is the fifth acquisition we have closed since 2019. Peoples expands our presence in Sidney and greater Shelby County, and we are excited to bring our community-oriented banking and financial services to customers across these markets. Our successful acquisition strategy combined with strong organic growth has helped increase our bank assets to over $2.8 billion. On behalf of everyone at F&M, we are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.